What is Adarza BioSystems?
Adarza Biosystems is the developer of a biological assay platform intended to measure clinical and point-of-care samples. The company’s label-free diagnostic platform is capable of simultaneous detection of hundreds of analytes in a single drop of fluid; enabling highly multiplexed protein detection with high sensitivity and specificity.
Company Leadership
bryan witherbee
president & CEO
Bryan joined Adarza BioSystems in January of 2017 to provide leadership as Adarza transitions from a technology developer to a commercial technology provider. Bryan’s career has spanned scientific, business development, and senior leadership positions in large research institutions and early stage startups in pharma, ag biotech, and life science technologies. He brings many years of experience with a successful track record in developing and commercializing new technologies. Bryan’s career started at Sigma Diagnostics where he developed and commercialized clinical immunoassays and coagulation reagents. Over the next 20 years he held various R&D leadership roles at Monsanto and Pfizer. He most recently served as Scientific Leader within the Genomics Division at Becton Dickinson (BD) where he provided leadership for the successful commercial launch of solutions for NextGen Sequencing and single cell genomics. Prior to that he was CSO at GenCell Biosystems, which was acquired by BD in 2014. His key accomplishments include identification and implementation of microfluidic technologies for molecular biology applications, frozen cell technologies, and various high throughput multiplexing technologies for systems biology. Bryan has a BS in Biochemistry from Truman State University.
Christopher Striemer
Vice President of technology
Chris is a founder and current Vice President of Technology for Adarza, responsible for technology development for the next generation Arrayed Imaging Reflectometry assay system. Pursuing applications relevant to his doctoral experience applying silicon nanostructures in biological applications and alternative energy fields, Chris spent the last 12 years working for university spinout companies that bridge the gap between precisely structured silicon chips and biological environments. He brings a wealth of expertise to Adarza in engineering process development, thin film optics and nanoscale materials. Chris has co-authored over 10 patent applications, has 30 peer-reviewed publications, has been the Principle Investigator on Phase I and II SBIR projects with total funding over $2.5M, and has been invited to present his work on optical biosensing and nanostructured materials at conferences in the U.S. and Europe. He received his PhD in Electrical and Computer Engineering from the University of Rochester.
Involved Industries
Be a Part of the Movement
We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.